LUFAX(06623): Ping An Consumer Finance and Shenzhen Ping An Asset Management enter into an agreement for asset transfer.
LuKong (06623) announced that on July 21, 2025, Ping An Consumer Finance and Shenzhen Ping An Asset Management...
LUFAX (06623) announced that on July 21, 2025, Ping An Consumer Finance and Shenzhen Ping An Asset Management (the winning bidder in the open bidding process) entered into an asset transfer agreement. According to the agreement, Ping An Consumer Finance conditionally agreed to transfer to Shenzhen Ping An Asset Management a total of approximately RMB 469 million in principal and interest related to multiple non-performing debts as of the cut-off date, for a consideration of RMB 36.44 million.
The debt assets are non-performing debts of Ping An Consumer Finance. The transfer of debt assets is an effective solution to revitalize credit resources and dispose of non-performing debts through market-oriented means, which can enhance the asset quality of Ping An Consumer Finance and further strengthen the foundation for its future business development. The book value of the debt assets as of the cut-off date is zero. As the debt assets have been written off, the consideration will be used by Ping An Consumer Finance to reverse impairment losses. The proceeds from the transfer of debt assets will be used as general operating funds for Ping An Consumer Finance.
Related Articles

The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.

Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).

CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.

Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).

CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.

RECOMMEND

Total Investment of 1.2 Trillion Yuan: Yarlung Zangbo Hydropower Project Commences, Creating Investment Opportunities in Water Conservancy, Power Grid, and Cement Sectors
21/07/2025

Another Major Order Secured for Humanoid Robots, Setting a Global Record
21/07/2025

Seven Ministries Jointly Release 11 Measures to Encourage Foreign-Invested Enterprises to Reinvest in China
21/07/2025